User profiles for "author:Lars Klareskog"

lars klareskog

professor in rheumatology Karolinska Institutet
Verified email at ki.se
Cited by 93384

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

D Tracey, L Klareskog, EH Sasso, JG Salfeld… - Pharmacology & …, 2008 - Elsevier
During the past 30 years, elucidation of the pathogenesis of rheumatoid arthritis, Crohn's
disease, psoriasis, psoriatic arthritis and ankylosing spondylitis at the cellular and molecular …

Immunity to citrullinated proteins in rheumatoid arthritis

L Klareskog, J Rönnelid, K Lundberg… - Annu. Rev …, 2008 - annualreviews.org
Antibodies to citrullinated proteins (ACPA), ie, to peptides posttranslationally modified by the
conversion of arginine to citrulline, are specific serological markers for rheumatoid arthritis …

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid …

DM Gerlag, K Raza, LGM Van Baarsen… - Annals of the …, 2012 - ard.bmj.com
The Study Group for Risk Factors for Rheumatoid Arthritis was established by the EULAR
Standing Committee on Investigative Rheumatology to facilitate research into the preclinical …

A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by …

L Klareskog, P Stolt, K Lundberg… - … : Official Journal of …, 2006 - Wiley Online Library
Objective To investigate whether smoking and HLA–DR shared epitope (SE) genes may
interact in triggering immune reactions to citrulline‐modified proteins. Methods In a case …

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

EA Stahl, S Raychaudhuri, EF Remmers, G Xie… - Nature …, 2010 - nature.com
To identify new genetic risk factors for rheumatoid arthritis, we conducted a genome-wide
association study meta-analysis of 5,539 autoantibody-positive individuals with rheumatoid …

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind …

L Klareskog, D van der Heijde, JP de Jager, A Gough… - The Lancet, 2004 - thelancet.com
Background Etanercept and methotrexate are effective in the treatment of rheumatoid
arthritis but no data exist on concurrent initiation or use of the combination compared with …

Genetics of rheumatoid arthritis contributes to biology and drug discovery

Y Okada, D Wu, G Trynka, T Raj, C Terao, K Ikari… - Nature, 2014 - nature.com
A major challenge in human genetics is to devise a systematic strategy to integrate disease-
associated variants with diverse genomic and biological data sets to provide insight into …

[HTML][HTML] STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus

EF Remmers, RM Plenge, AT Lee… - … England Journal of …, 2007 - Mass Medical Soc
Background Rheumatoid arthritis is a chronic inflammatory disease with a substantial
genetic component. Susceptibility to disease has been linked with a region on chromosome …

Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis

Y Liu, MJ Aryee, L Padyukov, MD Fallin… - Nature …, 2013 - nature.com
Epigenetic mechanisms integrate genetic and environmental causes of disease, but
comprehensive genome-wide analyses of epigenetic modifications have not yet …

[HTML][HTML] TRAF1–C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study

RM Plenge, M Seielstad, L Padyukov… - … England Journal of …, 2007 - Mass Medical Soc
Background Rheumatoid arthritis has a complex mode of inheritance. Although HLA-DRB1
and PTPN22 are well-established susceptibility loci, other genes that confer a modest level …